Related Experiment Video

Updated: Jan 22, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

945

The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering MUC5B

Qinghua Zhang1, Yan Wang1, Danhua Qu1

  • 1Department of Respiratory Medicine, The Second Hospital of Jilin University, Changchun, Jilin Province 130041, China.

Biomed Research International
|July 17, 2019
PubMed
Abstract

Insights

Overexpression of MUC5B protein contributes to idiopathic pulmonary fibrosis (IPF) by impairing airway defense. This review explores MUC5B

Area of Science:

  • Pulmonary Medicine
  • Molecular Biology
  • Genetics

Background:

  • Overexpression of the MUC5B protein is linked to idiopathic pulmonary fibrosis (IPF).
  • Limited data exists on the pathogenic roles and regulation of MUC5B in IPF.
  • MUC5B contributes to mucosal defense dysfunction in the distal airway.

Purpose of the Study:

  • To review the potential mechanisms driving MUC5B overexpression in IPF.
  • To explore the association between MUC5B overexpression and IPF pathogenesis.
  • To discuss implications for personalized IPF treatment.

Main Methods:

  • Literature review of MUC5B expression in IPF.
  • Analysis of MUC5B promoter polymorphism and epigenetic changes.
  • Examination of transcriptional factors and inflammatory mediators influencing MUC5B.
  • Discussion of signaling pathways affecting MUC5B expression.

Main Results:

  • MUC5B overexpression in terminal bronchi and honeycomb cysts causes host defensive dysfunction.
  • This dysfunction in the distal airway is implicated in IPF development.
  • Several factors including genetic, epigenetic, and inflammatory mechanisms may regulate MUC5B expression in IPF.

Conclusions:

  • Understanding MUC5B overexpression mechanisms is crucial for IPF research.
  • This knowledge may lead to novel, personalized therapeutic strategies for IPF.
  • Further exploration of MUC5B's role can advance IPF treatment.

More Related Videos

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo06:29

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

3.0K
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

1.6K

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
740
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
593
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
485
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
879